Related Experiment Video
Updated: Jun 13, 2026

08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Netrin-4 induces lymphangiogenesis in vivo
Frederic Larrieu-Lahargue1, Alana L Welm, Kirk R Thomas
1Program in Molecular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
Blood
|April 22, 2010
Summary
Netrin-4 promotes lymphatic vessel growth and metastasis in cancer. This study identifies Netrin-4 as a lymphangiogenic factor that could be a target for inhibiting cancer spread.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Netrin-4 is a secreted protein involved in development outside the nervous system.
- It regulates morphogenesis and vascular development in various tissues.
Purpose of the Study:
- To investigate the role of Netrin-4 in lymphatic endothelial cell function and tumor metastasis.
- To determine if Netrin-4 acts as a lymphangiogenic factor.
Main Methods:
- In vitro studies on human lymphatic endothelial cells (proliferation, migration, adhesion, tube formation, survival).
- In vivo studies in transgenic mice and breast tumor models.
- Analysis of intracellular signaling pathways (Akt, Erk, S6) and receptor expression (Unc5B, neogenin).
- Assessment of lymphatic permeability and tight junction protein regulation.
Main Results:
- Netrin-4 induced proliferation, migration, adhesion, tube formation, and survival of lymphatic endothelial cells.
- Netrin-4 promoted lymphatic and blood vessel growth in vivo and enhanced metastasis in mammary carcinoma.
- Netrin-4 increased lymphatic permeability by activating signaling pathways and down-regulating tight junction proteins.
Conclusions:
- Netrin-4 is a potent lymphangiogenic factor.
- Netrin-4 contributes to tumor dissemination and metastasis.
- Netrin-4 represents a potential therapeutic target for inhibiting cancer metastasis.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

